PuSH - Publikationsserver des Helmholtz Zentrums München

Bergant, V.* ; Yamada, S.* ; Grass, V.* ; Tsukamoto, Y.* ; Lavacca, T.* ; Krey, K.* ; Mühlhofer, M.T.* ; Wittmann, S.* ; Ensser, A.* ; Herrmann, A.* ; Vom Hemdt, A.* ; Tomita, Y.* ; Matsuyama, S.* ; Hirokawa, T.* ; Huang, Y.* ; Piras, A.* ; Jakwerth, C.A. ; Oelsner, M. ; Thieme, S.* ; Graf, A.* ; Krebs, S.* ; Blum, H.* ; Kümmerer, B.M.* ; Stukalov, A.* ; Schmidt-Weber, C.B. ; Igarashi, M.* ; Gramberg, T.* ; Pichlmair, A.* ; Kato, H.*

Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.

EMBO J. 41:e111608 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
The SARS-CoV-2 infection cycle is a multi-stage process that relies on functional interactions between the host and the pathogen. Here, we repurposed antiviral drugs against both viral and host enzymes to pharmaceutically block methylation of the viral RNA 2'-O-ribose cap needed for viral immune escape. We find that the host cap 2'-O-ribose methyltransferase MTr1 can compensate for loss of viral NSP16 methyltransferase in facilitating virus replication. Concomitant inhibition of MTr1 and NSP16 efficiently suppresses SARS-CoV-2 replication. Using in silico target-based drug screening, we identify a bispecific MTr1/NSP16 inhibitor with anti-SARS-CoV-2 activity in vitro and in vivo but with unfavorable side effects. We further show antiviral activity of inhibitors that target independent stages of the host SAM cycle providing the methyltransferase co-substrate. In particular, the adenosylhomocysteinase (AHCY) inhibitor DZNep is antiviral in vitro, ex vivo and in a mouse infection model, and synergizes with existing COVID-19 treatments. Moreover, DZNep exhibits a strong immunomodulatory effect curbing infection-induced hyperinflammation, and reduces lung fibrosis markers ex vivo. Thus, multi-specific and metabolic MTase inhibitors constitute yet unexplored treatment options against COVID-19.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Antivirals ; Covid-19 ; Host-directed ; Methyltransferase ; Sars-cov-2
ISSN (print) / ISBN 0261-4189
e-ISSN 1460-2075
Zeitschrift EMBO Journal, The
Quellenangaben Band: 41, Heft: 17, Seiten: , Artikelnummer: e111608 Supplement: ,
Verlag Wiley
Verlagsort Heidelberg, Germany
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)